Cancer is crafty. When one avenue driving its growth is blocked by drugs targeting that path, the malignancy often creates a detour, finding an alternative route to get around the roadblock.
Jun 14, 2011
0
1
A new targeted therapy for prostate cancer halts tumor growth in animals with advanced prostate cancer that is resistant to hormone therapy, a new study finds. The results will be presented Saturday at The Endocrine Society's ...
Jun 6, 2011
0
1
Resistance or strength training protects against the development of muscle pain in mice—and does so by activating androgen receptors, reports a basic science study in PAIN, the official publication of the International ...
Mar 31, 2022
0
10
The doctoral thesis of A. B. M. Kaiser Manjur, M.Sc., at the Faculty of Health Sciences, provides novel insights into two medically important transcription factors (TFs), glucocorticoid receptor (GR) and androgen receptor ...
Aug 18, 2021
0
3
Researchers say they have found a viable new therapeutic strategy for estrogen receptor-positive (ER+) breast cancer, even cancers that are resistant to current standard of care treatments. Their new preclinical study was ...
Mar 31, 2020
0
0
Researchers have discovered a new use for an old drug as a potential treatment for prostate cancer. The findings are published in the journal The Prostate.
Oct 3, 2018
0
2
Prostate cancer cells depend on signaling through the androgen receptor (AR) to grow and survive. Many anti-cancer therapies that target ARs are initially successful in patients, including a class of drugs known as CYP17A1 ...
May 2, 2017
0
2
Prostate cancer is one of the most common cancers in men. Tumor growth is critically regulated by the androgen receptor, and treatment strategies to lower androgens, such as testosterone, are a mainstay of clinical treatment. ...
Jul 21, 2016
0
1
When we think about sex hormones, notably estrogens and androgens, we usually associate them with sex, gender and body development. Like all hormones, they are chemical messengers, substances produced in one part of the body ...
Feb 23, 2016
0
1
Debiopharm International SA (Debiopharm), part of Debiopharm Group, a Swiss-based global biopharmaceutical company, today announced a collaboration in order to supply triptorelin pamoate 3.75 mg 1-month formulation for patients ...
Jan 14, 2016
0
0
